Covered recipient · General Payments record
VICTORIA A BLUCHER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$643.41
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $362.32 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Mylan Specialty L.P. | $61.46 | 2 |
| Novo Nordisk AS | $54.97 | 3 |
| Amgen Inc. | $50.40 | 2 |
| PFIZER INC. | $43.68 | 3 |
| Acerta Pharma LLC | $40.87 | 2 |
| Exact Sciences Corporation | $27.14 | 1 |
| ABBVIE INC. | $24.35 | 1 |
| Neurocrine BioSciences, Inc. | $23.95 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.77 | 1 |
| Lilly USA, LLC | $17.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.35 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106779317 | CMS |
| Amgen Inc. | $25.17 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117509486 | CMS |
| Amgen Inc. | $25.23 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117509488 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.03 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105661152 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.84 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105419012 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.77 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101333920 | CMS |
| Exact Sciences Corporation | $27.14 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114411725 | CMS |
| Lilly USA, LLC | $17.73 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135984222 | CMS |
| Mylan Specialty L.P. | $34.72 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147330061 | CMS |
| Mylan Specialty L.P. | $26.74 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147291762 | CMS |
| Neurocrine Biosciences, Inc. | $23.95 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150959508 | CMS |
| Novo Nordisk Inc | $14.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100440249 | CMS |
| Novo Nordisk Inc | $14.83 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100373158 | CMS |
| Novo Nordisk Inc | $26.14 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100436681 | CMS |
| PFIZER INC. | $13.56 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131120139 | CMS |
| PFIZER INC. | $14.30 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131365810 | CMS |
| PFIZER INC. | $15.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131946440 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.